Anmeldung erfolgt in Kürze...
Details werden geladen...
NRAS Mutations May Require Mutation-Guided Combination Therapies
Researchers show mutant NRAS and wild-type HRAS cooperate in cancer signaling, pointing to mutation-guided combination therapies.
Ähnliche Seiten
Largest ever ‘map’ of autism may hold clues for new targeted therapies - KVIA
https://kvia.com/health/cnn-health/2026/08/27/largest-ever-map-of-autism-may-hold-clues-for-new-targeted-therapies/
Bowel cancer before 50 may not be the same disease: Here’s what happens when it spreads to the liver - The Economic Times
https://economictimes.indiatimes.com/news/international/global-trends/bowel-cancer-before-50-may-not-be-the-same-disease-heres-what-happens-when-it-spreads-to-the-liver/articleshow/133714192.cms
GLP-1 drugs may result in better outcomes for cancer patients, study claims | The Independent
https://www.independent.co.uk/news/world/americas/glp-1-drugs-cancer-study-b2981601.html
Cancer may be breaking its own DNA to keep growing | ScienceDaily
https://www.sciencedaily.com/releases/2026/07/260731034204.htm
Night shifts disrupt the body clock and may raise the risk of dementia, heart disease and cancer
https://www.ynetnews.com/health_science/article/rjet6qphfl